Related Experiment Videos

Perspectives on chemoprevention agent selection and short-term clinical prevention trials

G J Kelloff¹, E T Hawk, J A Crowell

¹Chemoprevention Branch, National Cancer Institute (NCI), National Institutes of Health, Bethesda, Maryland 20892, USA.

European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)

|December 1, 1996

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Colorectal premalignancy is associated with consensus molecular subtypes 1 and 2.

Annals of oncology : official journal of the European Society for Medical Oncology·2018

Collaborating to Compete: Blood Profiling Atlas in Cancer (BloodPAC) Consortium.

Clinical pharmacology and therapeutics·2017

Lessons Learned: Transfer of the High-Definition Circulating Tumor Cell Assay Platform to Development as a Commercialized Clinical Assay Platform.

Clinical pharmacology and therapeutics·2017

I-SPY 2: an adaptive breast cancer trial design in the setting of neoadjuvant chemotherapy.

Clinical pharmacology and therapeutics·2009

Ursodeoxycholate/Sulindac combination treatment effectively prevents intestinal adenomas in a mouse model of polyposis.

Gastroenterology·2004

Prostate intraepithelial neoplasia in Noble rats, a potential intermediate endpoint for chemoprevention studies.

European journal of cancer (Oxford, England : 1990)·2004

See all related articles